Navigation Links
Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
Date:8/4/2008

PhenoSense(R) Integrase Now Enables Clinicians to Monitor Activity of New

Class of Potent Antiretroviral Drugs

SOUTH SAN FRANCISCO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced the launch of its PhenoSense(R) Integrase assay, built on Monogram's proprietary technology platform, PhenoSense(R). The assay directly measures the susceptibility of HIV to a new and potent class of integrase inhibitor drugs that blocks viral replication by preventing viral genes from integrating into the DNA of newly infected cells. Together with PhenoSense GT(R), PhenoSense Integrase provides the most complete picture of resistance to antiretroviral therapies.

PhenoSense Integrase along with other Monogram assays were used to support the clinical trials of the first commercially-available integrase inhibitor, Merck's Isentress(TM) (raltegravir), which received U.S. Food and Drug Administration (FDA) approval in October 2007. In Merck's phase III BENCHMRK trials, Monogram's PhenoSenseGT was used to select optimized drug regimens in the placebo and Isentress-containing treatment arms while PhenoSense Integrase was used to identify and characterize Isentress resistant viruses in treatment failures. The company is also actively involved in the clinical evaluation of Gilead's integrase inhibitor candidate, elvitegravir, currently in Phase III studies. In addition to drug resistance, PhenoSense Integrase also measures reductions in viral replication capacity associated with integrase inhibitor resistance that may help characterize viral fitness.

"Using new antiretroviral drugs correctly today, including HIV integrase inhibitors, is critically important since the pipeline for
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
2. Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference
3. Monogram Biosciences to Present at the JMP Securities Healthcare Conference
4. Monogram Biosciences Announces Third Quarter 2007 Financial Results Conference Call
5. Monogram Announces Third Quarter 2007 Financial Results
6. Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference
7. Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call
8. Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
9. Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts
10. Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology
11. Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... 21 CorVel Corporation,... "agent" services under the new,Medicare legislat...rd party,administrators and employers. The Compa...rvices for workers, compensation and general liabi...anding that service offering to,include communica...
(Date:11/21/2008)... York, Nov. 21 Eli Lilly...ncorporated (Nasdaq: IMCL ) today,announced the... tender offer,by Lilly,s wholly-owned subsidiary,...ing shares of ImClone at a price of $70.00 per sha...EST, on Thursday, November 20, 2008. , The ...
(Date:11/21/2008)...RNewswire-FirstCall/ -- Intellect Neurosciences, ...eutical company focused on development of disease-... prevention of Alzheimer,s disease released today ...el Chain, its Chairman and CEO. , , Dear S...e as Chairman and CEO of Intellect Neurosciences I...
(Date:11/20/2008)...20 Wyeth (NYSE: WYE ) ...has been promoted to President,Technical Operati... will be,responsible for all aspects of technical...ng its Pharmaceutical, BioPharma, Vaccine, Consume...Charles Portwood, 58, who has been,appointed to t...
Breaking Biology Technology:CorVel Announces MSA Agent Services 2CorVel Announces MSA Agent Services 3Lilly Completes Cash Tender Offer for ImClone Systems 2Lilly Completes Cash Tender Offer for ImClone Systems 3Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO 2Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO 3Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO 4Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO 5Wyeth Names Michael Kamarck President, Technical Operations & Product Supply 2
...sed start-up that is developing technologies for t... the 2006 Governor,s Business Plan Contest. , ,The...ony during the 2006 Wisconsin Entrepreneur,s Conf...siness plans to a panel of business judges. As a r...es, it will collect prizes of at least $50,000. , ...
...Jim Doyle ventured into what could have been enem...ontroversial stem cell patent of the Wisconsin Al...ion building on stem cell research, Doyle went aft...n , who supports limitations on federal funding fo...ck, Green charged that Doyle is unquestionably try...
... sport utility vehicle (SUV) fuel efficiency? , ,...of Wisconsin-Madison has spent the last three year...ient SUVs in North America. The principles behind ...uld one day be incorporated into mass-production h...Challenge X: Crossover to Sustainable Mobility ," ...
...indicators alone, you might conclude its a real-li...d town in the hit animated movie Cars. But just as..., maybe theres a more prosperous, real-life road a..., because without a healthy Milwaukee, most of Wis...tatistics confirms what most observers suspected: ...
Other Biology Technology:MatriLab wins Governor's Business Plan Contest 2MatriLab wins Governor's Business Plan Contest 3MatriLab wins Governor's Business Plan Contest 4Doyle, Green exchange stem cell salvos 2Doyle, Green exchange stem cell salvos 3Doyle, Green exchange stem cell salvos 4UW-Madison hybrid-vehicle team places second nationally 2It's an economic fact: As Milwaukee goes, so goes Wisconsin 2It's an economic fact: As Milwaukee goes, so goes Wisconsin 3
(Date:11/20/2008)... DigitalPersona, Inc., the,leader...d DigitalPersona,Personal 4.0, an easy-to-use ide...mbers and business users. DigitalPersona Personal ... biometrics, letting people use their fingerprints...nking, shopping, and other Web,sites -- to provid...
(Date:11/20/2008)... University of Pittsburgh published in the Nov. 20...nce of the first stages of the evolution of separa...es developed from hermaphroditic ancestors. These ... the majority of animal species developed into the...long ago for scientists to observe the transition....
(Date:11/20/2008)...NMS), an Austin-based startup cofounded by Mauro F...cience Center at Houston (UTHSC-Houston), to impro...er medications, has received a record $3.5 million...g Technology Fund (ETF). , NMS was one of six co...nnounced by Texas Gov. Rick Perry on Tuesday, Nov....
(Date:11/20/2008)...in German . , Halle/Saale. For the first t...view of which alien species are present in Europe,...t and society. More than 11,000 alien species have...ive Species Inventory for Europe), a unique three ...scientists, funded by the European Union that prov...
Breaking Biology News(10 mins):DigitalPersona Places Identity Protection at People's Fingertips 2DigitalPersona Places Identity Protection at People's Fingertips 3Two from one: Pitt research maps out evolution of genders from hermaphroditic ancestors 2Texas invests record $3.5 million in startup cofounded by UT's Mauro Ferrari 211,000 alien species invade Europe 2Peapod Offers First Ever Virtual Nutritionist 14537 1Peapod Offers First Ever Virtual Nutritionist 14537 2APhA Announces Plans for Executive Leadership Transition 14534 1APhA Announces Plans for Executive Leadership Transition 14534 2Environmental Operating Solutions Completes Initial Tranche of 242 5 Million Institutional Financing 4040 1Environmental Operating Solutions Completes Initial Tranche of 242 5 Million Institutional Financing 4040 2Environmental Operating Solutions Completes Initial Tranche of 242 5 Million Institutional Financing 4040 3Environmental Operating Solutions Completes Initial Tranche of 242 5 Million Institutional Financing 4040 4FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections 4037 1FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections 4037 2
...e May issue of The Journal of Geology provides fas...account for when examining dinosaur tracks. The au...mily of dinosaurs that includes the T. Rex and the...he effects of many different types of erosion on t...tebrate tracks in the rock record can be an invalu...
...ems resulting from farming argue for a shift towar...d energy and more recycling of energy and material...07 issue of BioScience. The author, Craig J. Pears...closed agricultural systems -- which he terms "reg...of biological resources, curtail greenhouse gas em...
...y 2nd issue of the online, open-access journal PLo...rests occurs in southern Madagascar, there are als...of forest cover was found to be substantial in the...uring the period 1993-2000. These dry forests have...d only in a particular region) in all of Madagasca...
...versity in St. Louis is making molecules the new-f...minuscule electrodes on a tiny computer chip that ...d to receptor sites. Kevin Moeller, Ph.D., Washing...; Sciences, is doing this so that the electrodes o...ehavior of up to 12,000 molecules at the same time...
Other Biology News:How to look at dinosaur tracks 2Madagascan tropical forests return thanks to better management and well-defined ownership 2Technique monitors thousands of molecules simultaneously 2Technique monitors thousands of molecules simultaneously 3Technique monitors thousands of molecules simultaneously 4
...on Buffers are membrane-filtered isotonic and enzy...ents and cell-conditioning agents in either Ca2+- ...2+- and Mg2+-free phosphate-buffered saline for ge...substrates and each other for studies requiring in...
Request Info
Mouse monoclonal [7A6] to NFAT2 ( Abpromise for all tested applications). entrezGeneID: 4772 SwissProtID: O95644
Attoglow Western Blot Enhancing Kit contains Millennium Enhancer which can significantly boost Western blot signals, and is compatible with other enhancing mechanisms to achieve multiplied enhancing
Biology Products: